Press release
Global Oligonucleotides Market to Surge from US$ 3.7 Billion in 2023 to Over US$ 13.1 Billion by 2034, Driven by Innovations in Gene Therapy, RNA-Based Treatments, and Diagnostic Advancements at a CAGR of 11.9%
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86409
What are Oligonucleotides?
Oligonucleotides are short sequences of nucleic acids-DNA or RNA-typically ranging from 13 to 25 base pairs, designed to bind with specific genetic sequences. These molecules are the foundation of many modern biotechnological and diagnostic tools. Due to their customizable nature and precision, they are widely used in:
Polymerase Chain Reaction (PCR)
DNA sequencing
Gene therapy
RNA interference (RNAi)
mRNA vaccine production
Drug development and diagnostics
Their unique role in manipulating, silencing, or amplifying genetic sequences makes them indispensable in modern molecular biology.
Key Growth Drivers
Rising Prevalence of Genetic and Chronic Diseases
An increase in conditions such as cancer, genetic disorders, and viral infections has escalated the need for targeted diagnostics and precision therapies. Oligonucleotide-based drugs are emerging as powerful tools to tackle such diseases at the genetic level.
Therapeutic Breakthroughs and Regulatory Approvals
The market has gained substantial momentum with multiple FDA-approved oligonucleotide therapeutics. In 2023 alone, four such drugs were approved:
Wainua (eplontersen) by AstraZeneca-Ionis
Rivfloza (nedosiran) by Dicerna Pharmaceuticals (Novo Nordisk)
Qalsody (tofersen) by Biogen-Ionis
Izervay (avacincaptad pegol) by Iveric Bio
These approvals validate the clinical potential of oligonucleotides and encourage further R&D and commercialization.
Advancements in Gene Editing and RNA Technologies
Technologies like CRISPR-Cas9 and RNAi are expanding the possibilities for treating previously incurable diseases. Oligonucleotides act as essential components in these cutting-edge therapeutic methods, further pushing their demand.
Customization and Precision
The ability to tailor oligonucleotides for specific genetic sequences makes them vital tools in personalized medicine and diagnostic applications. The market is benefitting from this trend toward individual-focused healthcare solutions.
Applications Across Multiple Domains
The versatility of oligonucleotides is reflected in their broad range of applications:
Molecular Biology: PCR primers, gene editing, and cloning
Drug Development: RNA-targeting and antisense drugs
Diagnostics: Genetic testing, cancer detection, infectious disease diagnostics
Gene Therapy: Correction or silencing of malfunctioning genes
Research: Nanotechnology and academic studies
Expanding Therapeutic Portfolio: Antisense, siRNA, and CpG
New categories of oligonucleotide drugs are constantly emerging. Key types include:
Antisense Oligonucleotides: Designed to bind mRNA and block protein translation.
siRNA (small interfering RNA): Silences genes by degrading mRNA after transcription.
CpG Oligonucleotides: Stimulate immune responses for therapeutic applications.
These innovations are creating pathways for new treatments and expanding the commercial potential of the market.
Regional Market Insights
North America Leads the Global Market
In 2023, North America held the largest market share, thanks to:
Advanced medical and healthcare infrastructure
High R&D investments from both government and private entities
Presence of leading biotech and pharmaceutical firms
U.S.-based companies like Ionis Pharmaceuticals and Alnylam Pharmaceuticals are pioneering the development of novel oligonucleotide therapies.
Asia Pacific Offers Lucrative Opportunities
Countries like China and India are rapidly expanding their healthcare infrastructure and biotechnology research. These emerging markets present substantial growth prospects, fueled by increasing disease burden, supportive government initiatives, and low-cost manufacturing advantages.
Key Industry Developments
February 2023: Ajinomoto Bio-Pharma Services introduced a new enzyme for manufacturing double-stranded oligonucleotides. Developed with the University of Shizuoka, the enzyme showcases improved RNA ligation capabilities and thermostability.
June 2022: Agilent Technologies launched MassHunter BioConfirm 12.0, a software that enhances oligonucleotide analysis, supporting high-resolution LC/MS for purity and sequence confirmation.
These innovations highlight the constant evolution of oligonucleotide production, quality control, and application analysis.
Leading Companies in the Oligonucleotides Market
The competitive landscape includes both established leaders and emerging innovators:
Thermo Fisher Scientific
Agilent Technologies
Merck
Ajinomoto Bio-Pharma Services
Integrated DNA Technologies
Eurofins Genomics
Kaneka Eurogentec
CordenPharma
Creative Biolabs
Nitto Avecia
Microsynth
Ribo Biotechnology
STA Pharmaceutical/Wuxi STA
These companies are focusing on product expansion, technology upgrades, and strategic collaborations to maintain their market presence.
Market Segmentation Overview
By Type:
Antisense Oligonucleotides
DNA Oligos
siRNA
Others (e.g., CpG oligonucleotides)
By Application:
Molecular Biology
Gene Therapy
Drug Development
Diagnostics
Others (e.g., nanotechnology, academic research)
By End-user:
Hospitals
Pharmaceutical & Biopharmaceutical Companies
Diagnostic Laboratories
Biotechnology Firms
CROs and CMOs
Academic Research Institutes
Final Outlook
The oligonucleotides market is on an accelerated growth trajectory, driven by revolutionary advancements in biotechnology, the rise of personalized medicine, and increasing regulatory approvals for oligonucleotide-based therapeutics. As both developed and emerging markets continue to invest in healthcare R&D and genomic medicine, oligonucleotides will play an increasingly central role in shaping the future of precision health and molecular diagnostics.
With continuous innovation and growing global demand, this sector is set to redefine the boundaries of gene-based therapeutics and diagnostics over the next decade.
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86409<ype=S
Explore Latest Research Reports by Transparency Market Research:
Bioprocess Containers Market- https://www.transparencymarketresearch.com/bioprocess-containers-market.html
Latex Medical Disposables Market- https://www.transparencymarketresearch.com/latex-medical-disposables-market.html
Microplate Washers Market- https://www.transparencymarketresearch.com/microplate-washer-market.html
Sample Preparation Market- https://www.transparencymarketresearch.com/sample-preparation-market.html
Laboratory Centrifuge Market- https://www.transparencymarketresearch.com/laboratory-centrifuge-market.html
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Oligonucleotides Market to Surge from US$ 3.7 Billion in 2023 to Over US$ 13.1 Billion by 2034, Driven by Innovations in Gene Therapy, RNA-Based Treatments, and Diagnostic Advancements at a CAGR of 11.9% here
News-ID: 4114789 • Views: …
More Releases from Transparency Market Research
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
Global Biophotonics Market Set for Robust Growth through 2034 Amid Rising Demand …
Biophotonics an interdisciplinary field merging photonics and biology-is revolutionizing diagnostics, therapeutics, and biomedical research. From detecting pathogens in food to diagnosing chronic conditions with non-invasive imaging techniques, biophotonics has become indispensable across medical and non-medical sectors. As the world seeks precision, safety, and efficiency in healthcare, the global biophotonics market is poised for exponential growth, driven by technological innovation, increasing healthcare demands, and enhanced investment in R&D.
Market Overview: The global…
Central Nervous System (CNS) Therapeutics Market Forecast 2034: Advancements in …
The central nervous system (CNS) plays a crucial role in controlling and coordinating bodily functions, and disorders affecting the CNS can have severe consequences on cognitive, motor, and sensory functions. Conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and multiple sclerosis are becoming increasingly prevalent worldwide, necessitating continued advancements in CNS therapeutics.
The global CNS therapeutics market was valued at US$ 102.4 billion in 2023 and is expected to grow…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
